SE Color

SE Color, a division of Southeast Life Sciences, is an organization dedicated to:

  • Support minority life science entrepreneurship
  • Increase investment in minority-owned life science businesses
  • Improve minority access to information and clinical opportunities

“Stairwell Chronicles”

with Dr. Jayne Morgan

Dr. Jayne Morgan is the Clinical Director of the Covid Taskforce at Piedmont Healthcare. In this series, she provides information on Covid, vaccines, and more in easy to digest 1-minute videos.

The Tuskegee Experiment?

Clinical Trials for The Culture

In the closing keynote of the 2020 AdvanSE Conference, Drs. Luther Clark, Jayne Morgan, Felix Sogade and Garin Wilson join moderator Tiffany Jordan-Winslow for a deep dive into the issue of African Americans distrust of the U.S. healthcare industry and its implications for the Covid era.

SE Color
Covid Webinar

Education on Covid, reasons to be vaccinated and the cause of inclusion into clinical trials. We bringing together a researcher, a clinical trial expert, and a prominent member of the black community to take a step toward alleviating distrust by discussing the issues and concerns.

Minorities in Clinical Trials

 African Americans make up 13.4% of the US population, yet represent less than 7% of participants in clinical trials.

SE Color’s initial effort will focus on increasing the number of minorities in clinical trials. Our initial priorities are to to share information on clinical trials available throughout the southeast, building community trust in clinical trials, and working with state and local leaders to addressing concerns from the community. As part of this, SE Color will focus on education and community engagement.

map-southeast

Available Clinical Trials in your State

Alabama

Visit this website for list trials in this state.

Florida

Visit this website for list trials in this state.

Georgia

Visit this website for list trials in this state.

North Carolina

Visit this website for list trials in this state.

South Carolina

Visit this website for list trials in this state.

Tennessee

Visit this website for list trials in this state.

Virginia

Visit this website for list trials in this state.

ADVISORY BOARD

Kornelius Bankston

Robert Benson

womens-board-jayne-morgan
Director of Cardiovascular Research – Piedmont Heart Institute

Jayne Morgan, Vice Chair

President & CEO, Virginia BIO

John Newby

Karl D. Pendergrass

Co-Founder & Chief Development Officer, Acclinate

Tiffany Jordan-Whitlow

Kornelius Bankston

Kornelius is the managing partner of techPLUG. He leads the firm’s strategy and business development efforts. He’s a graduate of Morehouse College (BSc. Chemistry), Emory University (MSc. Biomolecular Chemistry) and the Georgia Institute of Technology (MBA- Management of Technology).

After graduating from Emory University, Kornelius worked for a startup founded by Dr. Dennis Liotta as a business development intern. He went on to become a project manager with the Georgia Department of Economic Development where he worked to help recruit Baxter (now known as Takeda) to Georgia. He moved on to manage Morehouse School of Medicine’s first Office of Technology Transfer and Office of Industry Sponsored Clinical trials.  He was able to help underserved populations who traditionally do not participate in clinical trials to become more engaged in clinical research. Kornelius served as the director of bioscience ecosystem expansion for the Metro Atlanta Chamber where he worked to recruit bioscience companies to the Metro Atlanta region.  While at the Metro Atlanta Chamber he launched Global Health ATL, www.globalhealthatl.com, to promote Atlanta as the Center for Global Health. Most recently, Kornelius served as the director of business development for Color Genomics leading the company’s southeast business development efforts. Kornelius leads Strategic Partnerships for Simple HealthKit a social impact diagnostic company located in Silicon Valley. He also serves as a mentor for Techstars and a member of the Advisory Board for Paincare Labs.

Robert Benson

Robert E. Benson, Jr. is a corporate attorney and a Partner in King & Spalding’s Mergers & Acquisitions and Private Equity practices.  Robert represents advises public and private companies, private equity funds, boards of directors, investors, inventors and special committees in significant corporate transactions, including domestic and cross-border M&A transactions, spin-offs, divestitures, joint ventures, special purpose acquisition company (SPAC) transactions, complex commercial agreements and strategic investments.  Robert also advises clients on a variety of corporate governance and general corporate and securities matters, including the commercialization and development of innovations in tech, fin-tech, green tech, energy, automotive and life science industry sectors.

Robert is a native Atlantan and a graduate of Harvard Business School, Harvard Law School and Washington and Lee University.  Robert is a member of the Board of Trustees of Odyssey Atlanta and is a member of the advisory board of SE COLOR.  Robert is also the founder of the Inkwell, a monthly networking breakfast for diverse professionals in Atlanta.  Robert leads the Core Committee for the Atlanta University Center InterVarsity Christian Fellowship and is a former member of the Regional Board for Young Life Gotham City. Robert is a member of Southwest Christian Fellowship Church in South Atlanta.

Robert was recognized as a New York Super Lawyers Rising Star in 2016 and 2015 and a Georgia Super Lawyers Rising Star in 2018.

womens-board-jayne-morgan

Director of Cardiovascular Research – Piedmont Heart Institute

Jayne Morgan, Vice Chair

Dr. Jayne Morgan is a Cardiologist with extensive experience in clinical patient management, as well as pharmaceutical and biotech research. For the past 2 decades she has focused on improving the care and quality of life measures for patients from heterogenous populations, including end-of-life patients without further medical options.

Serving in the roles of both Clinical Development and Medical Affairs for global pharmaceutical and device companies for the past 10 years, she has successfully led Phase II and III programs globally, and Phase IV programs in Europe. In these roles, her background includes leadership and accountability for research projects with oversight of a $52 million dollar budget within a $4.5 billion company.

As the driver of the cardio-renal and heart failure programs (sponsored and funded by Solvay Pharmaceuticals), and providing the scientific guidance as a consultant to the MitraClip programs (funded and sponsored by Abbott Vascular), her experience in the design and execution of large international clinical trials for both devices and pharmaceuticals is well established. Acknowledged with both the Solvay Cardio-Metabolic Strategic Paper Award and People to People Ambassadorship for vulnerable global populations, she has selected and led many scientific panel experts including Steering Committees, Adjudication Committees, and Data Safety Monitoring Board Committees, and has also served on regulatory panels for both the FDA and EMA.

Following high school graduation as Valedictorian, Dr. Morgan went on to complete her B.S. degree in Biology and Biochemistry from Spelman College; her M.D. degree from Michigan State University; Internal Medicine Residency from George Washington University; and Cardiology Fellowship at Mount Sinai Medical Center including completion of a Pacemaker Sub-Fellowship. She has treated patients in both rural primary care settings, as well as within academic institutions as the Associate Professor of Medicine at the Cleveland Clinic Florida, and is published in both the American Heart Journal and recognized by the Heart Failure Society for her work on Adenosine Receptor Antagonists. Further, Dr. Morgan has received numerous distinctions in Principles of Radiation Physics, and RadioPharmaceuticals and Chemistry in Nuclear Medicine. In fact, most recently, she served as the CMO (Chief Medical Officer) of the American Chemistry Council where she introduced new stakeholders, advocated for senate bill reforms, and developed a strategy and new direction for their research program including securing funding from the Board of $5 million dollars annually for 4 years.

Dr. Morgan has also served as a 6 year Board member of the Make-A-Wish Foundation of Georgia and Alabama and the Calvary Childrens Home (orphanage). Currently, she is a Founding Member of Biotechnology for Women, member of the AHA (American Heart Association), AMA (American Medical Association), AWMA (American Womens Medical Association), and the ABC (Association of Black Cardiologists). Additionally, she is recognized as an Industry Fellow for the GRA (Georgia Research Alliance) focused on the development and commercialization of biotech and pharma innovations into viable companies and partnerships here in the state of Georgia.

Currently, she is the Director of Cardiovascular Research at the Piedmont Research Institute where she is responsible for all drug, device, and drug/device combination trials in both the Cardiovascular and Peripheral Vascular space. Bringing to an organization over 20+ years of clinical and industry experience, and a demonstrated record of strategic planning, management, and execution of trials to support the medical and scientific platform of an organization, Dr. Morgan is able to leverage a wealth of qualifications in business development, scientific rigor/conduct, medical education, and communication.

President & CEO, Virginia BIO

John Newby

Karl D. Pendergrass

Karl Pendergrass, Ph.D. is a Regional Medical Scientific Director at Merck & Co., Inc., covering multiple states in the southeastern United States.  He has held this position since 2014.  Growing up in Spartanburg, SC, Karl attended Wake Forest University, earning a Bachelor’s of Science degree in Health and Exercise Science and a minor in Chemistry.  In addition to his academic pursuits, Karl was a member of Wake Forest University’s football team as a defensive back.

After graduating from Wake Forest, he continued his education by taking coursework at Winston-Salem State University, completing the Postbaccalaureate Research Education Program (PREP) at Wake Forest University School of Medicine, and earning a Doctorate of Philosophy in Physiology and Pharmacology.  For his doctorate, he specialized in basic science research in hypertension from Wake Forest University School of Medicine.  Karl then completed a postdoctoral fellowship in the Division of Cardiology at Emory University and the Biomedical Engineering department at Georgia Institute of Technology.

Throughout his academic research career, Karl has published articles in highly-ranked journals and received multiple awards and research funding, such as the UNCF/Merck Postdoctoral fellowship.  While in Winston-Salem, Karl lectured in the Master’s in Physical Therapy program and tutored students in numerous science courses.  He also led and assisted multiple students and mentees in their academic and professional scientific pursuits.  Karl continues to cultivate a passion for scientific innovation and health promotion through activities in church as co-director of the Health Ministry at the Historic Ebenezer Baptist Church, formerly serving as a volunteer reviewer for the UNCF/Merck Science Initiative (undergraduates) and UNCF STEM Scholars, and speaking at HBCUs and PWIs.

Co-Founder & Chief Development Officer, Acclinate

Tiffany Jordan-Whitlow

Tiffany is an innovator and entrepreneur with 10 years of business management expertise. She’s experienced in all aspects of business formation, operation, strategic messaging, and marketing. In addition, she is a lifelong learner committed to staying on top of the best current and emerging business practices. She works hard to continue strengthening communities while fostering civic engagement through service and volunteering. At Acclinate Tiffany is able to utilize her relentless drive for diversity, equity, and inclusion to transform clinical research.

In 2017, Tiffany founded, Driven Solutions, where she continuously works to find solutions for the everyday needs of clients while helping them maximize their full potential in order to reach goals. At a young age Tiffany made a name for herself here in Rocket City by being a dedicated volunteer to United Way of Madison County and a hard worker. After managing a well known dental practice for 5 years Tiffany worked for the Huntsville/Madison County Chamber of Commerce. Through the years she has established herself as a trustworthy, dedicated and diligent young professional. She was recently recognized as one of the top 40 young professionals under the age of 40 by 256 Magazine and a finalist for the 2018 & 2019 Entrepreneur Awards by al.com and the Catalyst Center for Business & Entrepreneurship.

Tiffany has strong affiliations in the business community where she serves as an active board member of Urban Engine, Vice President of the Board of Directors for Nexus Energy Center, Advisor to the United Way of Madison County, Community Partner to Monrovia Middle School and Hampton Cove Middle School, A member of the National Space Club, A Kids to Love advocate and community partner, TRC Volunteer for the Decatur/Morgan County Chamber of Commerce, a member of the Women’s Economic Development Council, and a member of Mayor Battle’s Diversity & Inclusion Council. She works hard to form bonds with businesses to promote different perspectives which encourage the leaders, employees and our entire community to evolve.